{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:29:38Z","timestamp":1791289778035,"version":"4.3.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.2215\/cjn.01360215","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T22:19:41Z","timestamp":1440713981000},"page":"1773-1782","source":"Crossref","is-referenced-by-count":57,"title":["Eculizumab in Pediatric Dense Deposit Disease"],"prefix":"10.2215","volume":"10","author":[{"given":"Michiel J.S.","family":"Oosterveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Garrelfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Florquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris J.T.H.","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Davin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia H.M.","family":"Bouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietrik J.","family":"Schriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap W.","family":"Groothoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20230601","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ki.2012.80","article-title":"C3 glomerulopathy: What\u2019s in a name?","volume":"82","author":"D\u2019Agati","year":"2012","journal-title":"Kidney Int"},{"key":"R2-12-20230601","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification.","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R3-12-20230601","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: Consensus report.","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"R4-12-20230601","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2007030356","article-title":"New approaches to the treatment of dense deposit disease.","volume":"18","author":"Smith","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R5-12-20230601","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.ajkd.2010.09.021","article-title":"Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis.","volume":"57","author":"Angelo","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R6-12-20230601","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1681\/ASN.2005020175","article-title":"Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.","volume":"16","author":"Braun","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R7-12-20230601","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MNH.0b013e32835da24c","article-title":"Treatment options for C3 glomerulopathy.","volume":"22","author":"Nester","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R8-12-20230601","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00467-009-1322-7","article-title":"Membranoproliferative glomerulonephritis.","volume":"25","author":"Alchi","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R9-12-20230601","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00467-011-2059-7","article-title":"Clinical features and outcomes of 98 children and adults with dense deposit disease.","volume":"27","author":"Lu","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R10-12-20230601","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.03480708","article-title":"Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.","volume":"4","author":"Nasr","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-12-20230601","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.","volume":"350","author":"Hillmen","year":"2004","journal-title":"N Engl J Med"},{"key":"R12-12-20230601","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R13-12-20230601","first-page":"201568","article-title":"Blockade of alternative complement pathway in dense deposit disease.","volume":"2014","author":"Berthe-Aucejo","year":"2014","journal-title":"Case Rep Nephrol"},{"key":"R14-12-20230601","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis.","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-12-20230601","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMc1112273","article-title":"Eculizumab in a patient with dense-deposit disease.","volume":"366","author":"Daina","year":"2012","journal-title":"N Engl J Med"},{"key":"R16-12-20230601","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00467-013-2503-y","article-title":"Eculizumab and recurrent C3 glomerulonephritis.","volume":"28","author":"Gurkan","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R17-12-20230601","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1600-6143.2011.03923.x","article-title":"Recurrent dense deposit disease after renal transplantation: An emerging role for complementary therapies.","volume":"12","author":"McCaughan","year":"2012","journal-title":"Am J Transplant"},{"key":"R18-12-20230601","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-013-2748-5","article-title":"Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy.","volume":"29","author":"Ozkaya","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R19-12-20230601","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00467-013-2711-5","article-title":"Rituximab fails where eculizumab restores renal function in C3nef-related DDD.","volume":"29","author":"Rousset-Rouvi\u00e8re","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R20-12-20230601","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00467-014-2839-y","article-title":"Eculizumab in dense-deposit disease after renal transplantation.","volume":"29","author":"S\u00e1nchez-Moreno","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R21-12-20230601","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of dense-deposit disease.","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N Engl J Med"},{"key":"R22-12-20230601","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2012.07.028","article-title":"Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: A focus on eculizumab.","volume":"61","author":"Schmidtko","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R23-12-20230601","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1681\/ASN.2011121186","article-title":"Pathology after eculizumab in dense deposit disease and C3 GN.","volume":"23","author":"Herlitz","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R25-12-20230601","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.0601094103","article-title":"Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.","volume":"103","author":"Pickering","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-12-20230601","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.","volume":"118","author":"Rose","year":"2008","journal-title":"J Clin Invest"},{"key":"R27-12-20230601","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R28-12-20230601","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ki.2013.340","article-title":"Toward a working definition of C3 glomerulopathy by immunofluorescence.","volume":"85","author":"Hou","year":"2014","journal-title":"Kidney Int"},{"key":"R29-12-20230601","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(82)90386-6","article-title":"A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes.","volume":"51","author":"Rother","year":"1982","journal-title":"J Immunol Methods"},{"key":"R30-12-20230601","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"R31-12-20230601","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molimm.2013.05.221","article-title":"An international serum standard for application in assays to detect human complement activation products.","volume":"56","author":"Bergseth","year":"2013","journal-title":"Mol Immunol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201510000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:43Z","timestamp":1786369543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201510000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.01360215","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}